Related Experiment Video
Updated: Jun 21, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
Published on: October 16, 2018
Sequential transmission and long-term persistence of an HIV strain partially resistant to protease inhibitors
Ennio Polilli1, Francesco Di Masi, Federica Sozio
1Clinical Pathology Unit, "Spirito Santo" Hospital, Pescara, Italy.
Abstract:
Transmission of drug-resistant HIV-1 variants has been increasingly documented. The most commonly observed resistance-associated mutations are thymidine analogue mutations as well as non-nucleoside reverse transcriptase inhibitor mutations. We report on a case of secondary transmission of a protease inhibitor (PI) primary mutation from an infected untreated subject to his sexual partner. Sequences isolated from the 2 patients showed a high level of identity (>99%), both carrying the major IAS PI mutation M46I. The latter mutation persisted in the bloodstream of the female partner 1 year after its first detection.
Insights
Secondary transmission of drug-resistant HIV-1 occurred, involving a protease inhibitor (PI) mutation. This specific PI mutation was detected in both partners and persisted in the female partner for over a year.
Area of Science:
- Virology
- Infectious Diseases
- Genetics
Background:
- Drug-resistant human immunodeficiency virus type 1 (HIV-1) transmission is a growing concern.
- Commonly observed resistance mutations include thymidine analogue mutations and non-nucleoside reverse transcriptase inhibitor mutations.
Observation:
- A case of secondary transmission of a primary protease inhibitor (PI) mutation is reported.
- The mutation was transmitted from an untreated infected male subject to his sexual partner.
Findings:
- Sequences from both patients exhibited high identity (>99%).
- Both individuals carried the major IAS PI mutation M46I.
- The M46I mutation remained detectable in the female partner's bloodstream for one year post-detection.
Implications:
- This case highlights the potential for transmission of specific PI resistance mutations.
- Understanding transmission dynamics of drug-resistant HIV-1 is crucial for treatment and prevention strategies.
- The persistence of the mutation suggests long-term implications for treatment efficacy in the transmitted partner.
More Related Videos
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
Related Concept Videos
Retrovirus Life Cycles
Size and Structure of Viral Genomes
Sexually Transmitted Infections
Inhibitors of Virion Maturation and Assembly
Viral Mutations
Viruses with RNA Genomes